Latest current cash for CHMMF: $800K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), CHMMF shows a current cash of $800K. That compares with $5.8M in the prior-year period — down 86.1% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, CHMMF's current cash is now $800K (was $5.8M) — a 86.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Chimeric Therapeutics Limited is outperforming or lagging.
Tracking CHMMF's current cash over time shows whether Chimeric Therapeutics Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $800K That compares with $5.8M in the prior-year period — down 86.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current cash page, Stockcircle has Chimeric Therapeutics Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $800K) with ownership activity and broader fundamentals.
Chimeric Therapeutics Limited's current cash is $800K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.